KIAA1737 Activators
KIAA1737, known as a CLOCK interacting pacemaker, plays a pivotal role in the regulation of circadian rhythms. Activation of this protein can be achieved through the modulation of intracellular signaling pathways that converge upon its stabilization and phosphorylation state. For instance, the elevation of cyclic AMP (cAMP) levels within cells through various means leads to the activation of protein kinase A (PKA), which in turn can phosphorylate KIAA1737, thereby enhancing its stability and function in maintaining the circadian clock. This can be accomplished by compounds that directly stimulate adenylyl cyclase or by inhibiting phosphodiesterase enzymes, which would otherwise degrade cAMP. Additionally, the use of ATP analogs that bind and activate kinases may also result in the phosphorylation and subsequent activation of KIAA1737, further evidencing the complex regulatory network this protein is a part of.
Conversely, the inhibition of glycogen synthase kinase-3 (GSK-3), a kinase that targets KIAA1737 for degradation, can result in the increased stability and activity of KIAA1737. This is achieved through chemicals that directly inhibit GSK-3, leading to a decrease in the phosphorylation of KIAA1737, which prevents its degradation and promotes its role in the circadian rhythm. Neurosteroids that influence neuronal excitability and may impact circadian regulation also play a role in modulating the activity of KIAA1737.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Inhibits glycogen synthase kinase-3 (GSK-3), which is known to phosphorylate and destabilize KIAA1737. By inhibiting GSK-3, lithium chloride indirectly stabilizes KIAA1737, promoting its activity in the regulation of circadian rhythms. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Phosphodiesterase-4 (PDE4) inhibitor that prevents cAMP breakdown, effectively raising intracellular cAMP levels. This elevation can activate protein kinase A (PKA), which then can phosphorylate KIAA1737, resulting in its activation. | ||||||
SB-216763 | 280744-09-4 | sc-200646 sc-200646A | 1 mg 5 mg | $71.00 $202.00 | 18 | |
GSK-3 inhibitor that prevents the phosphorylation and subsequent degradation of KIAA1737, thereby allowing it to accumulate and enhance its role in circadian rhythm control. | ||||||
Dexamethasone | 50-02-2 | sc-29059 sc-29059B sc-29059A | 100 mg 1 g 5 g | $91.00 $139.00 $374.00 | 36 | |
Glucocorticoid receptor agonist that can synchronize circadian rhythms and has been shown to regulate the expression of clock genes, indirectly influencing the activity of KIAA1737. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
A cAMP analog that resists degradation by phosphodiesterases, maintaining elevated levels of cAMP, which can lead to the activation of PKA and subsequent phosphorylation of KIAA1737. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
MEK inhibitor that indirectly leads to the stabilization of KIAA1737 by altering signaling pathways that impinge on the circadian rhythm, of which KIAA1737 is a component. | ||||||
Harmine | 442-51-3 | sc-202644 sc-202644A sc-202644B sc-202644C sc-202644D sc-202644E sc-202644F | 250 mg 500 mg 1 g 10 g 50 g 100 g 500 g | $53.00 $104.00 $126.00 $551.00 $1467.00 $2611.00 $11455.00 | 2 | |
Dual-specificity tyrosine-regulated kinase (DYRK) inhibitor, which can prevent phosphorylation of downstream proteins. This may stabilize and activate KIAA1737 by inhibiting kinases that target it for degradation. | ||||||
GSK-3 Inhibitor XVI | 252917-06-9 | sc-221691 sc-221691A | 5 mg 25 mg | $180.00 $610.00 | 4 | |
Potent GSK-3 inhibitor that by preventing the phosphorylation of KIAA1737, allows for its stabilization and enhances its ability to regulate circadian rhythms. | ||||||
Adenosine 3′,5′-cyclic Monophosphate, N6-Benzoyl-, Sodium Salt | 30275-80-0 | sc-300167 | 10 µmol | $324.00 | 1 | |
Selective activator of PKA that leads to the phosphorylation of proteins within the signaling pathways, potentially including KIAA1737, thereby promoting its activity. | ||||||
Pregnenolone sulfate sodium salt | 1852-38-6 | sc-301609 | 50 mg | $99.00 | 2 | |
Can modulate neuronal excitability and has been implicated in the regulation of circadian rhythms, potentially affecting the activity of KIAA1737. | ||||||